Health Care & Life Sciences » Pharmaceuticals | Bristol-Myers Squibb Co.

Bristol-Myers Squibb Co. | Mutual Funds

Mutual Funds that own Bristol-Myers Squibb Co.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Health Care Fund
50,597,061
3.1%
3,908,700
6.09%
06/30/2018
Vanguard Total Stock Market Index Fund
41,084,643
2.52%
164,908
0.33%
07/31/2018
Vanguard 500 Index Fund
29,600,014
1.81%
34,360
0.4%
07/31/2018
Vanguard Wellington Fund
24,029,236
1.47%
178,145
1.43%
06/30/2018
Dodge & Cox Stock Fund
19,848,739
1.22%
3,000,000
1.61%
06/30/2018
SPDR S&P 500 ETF
18,072,406
1.11%
208,537
0.4%
09/06/2018
Vanguard Institutional Index Fund
15,812,404
0.97%
17,192
0.4%
07/31/2018
Government Pension Fund - Global (The)
13,886,965
0.85%
1,771,248
0.1%
12/31/2017
Vanguard Growth Index Fund
11,511,496
0.71%
-33,482
0.81%
07/31/2018
Fidelity Spartan 500 Index Fund
10,887,978
0.67%
128,426
0.4%
07/31/2018

About Bristol-Myers Squibb

View Profile
Address
430 East 29th Street
New York New York 10154
United States
Employees -
Website http://www.bms.com
Updated 07/08/2019
Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.